Author:
Fisher Alexander V.,Ronnekleiv-Kelly Sean M.
Publisher
Springer Science and Business Media LLC
Reference130 articles.
1. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg. 1996;224(4):463–73.
http://www.ncbi.nlm.nih.gov/pubmed/8857851
. Accessed 27 March 2018.
2. Altekruse SF, Petrick JL, Rolin AI, et al. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States. PLoS ONE. 2015;10(4):e0120574.
https://doi.org/10.1371/journal.pone.0120574
.
3. Data are from the multiple cause of death files, 1999–2016 as compiled from data provided by the 57 vital statistics jurisdictions through the VSCP. Centers for Disease Control and Prevention, National Center for Health Statistics. Underlying Cause of Death 1999–2016 on CDC WONDER Online Database, released December 2017.
4. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273–81.
https://doi.org/10.1056/NEJMoa0908721
.
5. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755–62.
https://doi.org/10.1097/01.sla.0000251366.62632.d3
.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献